«

Recalled Ranitidine: Alternatives for Indigestion, Heartburn Relief

Read: 1827


Information on Ranitidine, the Discontinued Medication for Indigestion and Heartburn

Introduction:

Ranitidinea medication that was once used to alleviate symptoms of indigestion, heartburn, acid reflux, gastro-oesophageal reflux disease GORD, and stomach ulcershas been recalled globally due to concerns about an impurity linked to cancer risk in animal studies. As of now, it is unavlable across the United Kingdom and worldwide.

Ranitidine functioned by reducing gastric acid production, ding those suffering from these conditions. However, if you're experiencing indigestion, heartburn, or recurrent acid reflux issues, please consult your healthcare professional for advice on alternative medications.

Guidance:

For individuals struggling with indigestion, heartburn, and acid refluxconditions commonly known as GORDwe recomm seeking guidance from a medical practitioner who can prescribe suitable alternatives based on their clinical judgment.

Additional Resources:

Article Review Date: March 26, 2024

Next Review Expected: March 26, 2027

Support Provided:

Home

Health Information A-Z

Living Well

Mental Health

Care Support

Pregnancy

NHS Services

Coronavirus COVID-19

NHS App

Finding Your NHS Number

Viewing GP Health Record

Checking Test Results Online

Understanding the NHS

Travel Health and Abroad Services

Other Health Resources

Platform Tools:

Profile Editor Login

Feedback Submission Page

Accessibility Statement

Our Policies

Cookie Policy

Organizational Detls:

About Us

Ask for Feedback

Legal Information:

Copyright Crown Copyright

of Document
This article is reproduced from: https://www.nhs.uk/medicines/ranitidine/

Please indicate when reprinting from: https://www.p092.com/Drug_capsules/Ranitidine_Recall_Medication.html

Alternative Medications for Heartburn Ranitidine Recall for Cancer Risk Gastro Oesophageal Reflux Disease Management Discontinued Indigestion Treatment Options Ranitidine Impurity and Health Concerns Global Availability of the Discontinued Drug